Literature DB >> 7829796

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products.

P M Okin1, M J Roman, R B Devereux, P Kligfield.   

Abstract

OBJECTIVES: This study was conducted to validate the hypothesis that the product of QRS voltage and duration, as an approximation of the time-voltage area of the QRS complex, can improve the electrocardiographic (ECG) detection of echocardiographically determined left ventricular hypertrophy and to further assess the relative contribution of QRS duration to the ECG detection of hypertrophy.
BACKGROUND: The ECG identification of left ventricular hypertrophy has been limited by the poor sensitivity of standard voltage criteria alone. However, increases in left ventricular mass can be more accurately related to increases in the time-voltage area of the QRS complex than to changes in QRS voltage or duration alone.
METHODS: Standard 12-lead ECGs and echocardiograms were obtained for 389 patients, including 116 patients with left ventricular hypertrophy. Simple voltage-duration products were calculated by multiplying Cornell voltage by QRS duration (Cornell product) and the 12-lead sum of voltage by QRS duration (12-lead product).
RESULTS: In a stepwise logistic regression model that also included Cornell voltage, Sokolow-Lyon voltage, age and gender, QRS duration remained a highly significant predictor of the presence of left ventricular hypertrophy (chi-square 26.9, p < 0.0001). At a matched specificity of 96%, each voltage-duration product significantly improved sensitivity for the detection of left ventricular hypertrophy compared with simple voltage criteria alone (Cornell product 37% vs. Cornell voltage 28%, p < 0.02, and 12-lead product 50% vs. 12-lead voltage 43%, p < 0.005). Sensitivities of both the Cornell product and the 12-lead product were significantly greater than the 27% sensitivity of QRS duration alone (p < 0.01 vs. p < 0.001), the 20% sensitivity of a Romhilt-Estes point score > 4 (p < 0.001) and the 33% sensitivity of the best-fit logistic regression model in this cohort (p < 0.05 vs. p < 0.001).
CONCLUSIONS: QRS duration is an independent ECG predictor of the presence of left ventricular hypertrophy, and the simple product of either Cornell voltage or 12-lead voltage and QRS duration significantly improves identification of left ventricular hypertrophy relative to other ECG criteria that use QRS duration and voltages in linear combinations.

Entities:  

Mesh:

Year:  1995        PMID: 7829796     DOI: 10.1016/0735-1097(94)00371-v

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   27.203


  80 in total

1.  Assessment of voltage criteria for left ventricular hypertrophy in adult hypertensives in south-western Nigeria.

Authors:  Oluwadare Ogunlade; Anthony Olubunmi Akintomide
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

2.  Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Jonathan Chrispin; Aditya Jain; Elsayed Z Soliman; Eliseo Guallar; Alvaro Alonso; Susan R Heckbert; David A Bluemke; João A C Lima; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

3.  A comparison of Cornell and Sokolow-Lyon electrocardiographic criteria for left ventricular hypertrophy in a military male population in Taiwan: the Cardiorespiratory fitness and HospItalization Events in armed Forces study.

Authors:  Fang-Ying Su; Yi-Hwei Li; Yen-Po Lin; Chung-Jen Lee; Chih-Hung Wang; Fan-Chun Meng; Yun-Shun Yu; Felicia Lin; Hsien-Tsai Wu; Gen-Min Lin
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

4.  P-wave morphologic characteristics predict cardiovascular events in a community-dwelling population.

Authors:  Tomoyuki Kabutoya; Shizukiyo Ishikawa; Joji Ishikawa; Satoshi Hoshide; Kazuomi Kario
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

5.  Electrocardiographic signs of left ventricular hypertrophy in obese patients: what criteria should be used?

Authors:  Giuseppe Germano
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-08-05

6.  Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.

Authors:  Manuel A Gómez-Marcos; José I Recio-Rodríguez; Emiliano Rodríguez-Sánchez; Yolanda Castaño-Sánchez; Angela de Cabo-Laso; Benigna Sánchez-Salgado; Carmela Rodríguez-Martín; Carmen Castaño-Sánchez; Leticia Gómez-Sánchez; Luis García-Ortiz
Journal:  BMC Public Health       Date:  2010-03-18       Impact factor: 3.295

7.  Comparing the probability of stroke by the Framingham risk score in hypertensive Korean patients visiting private clinics and tertiary hospitals.

Authors:  Cheol Ung Choi; Chang Gyu Park
Journal:  BMC Neurol       Date:  2010-09-08       Impact factor: 2.474

8.  Electrocardiographic left ventricular hypertrophy Cornell product is a feasible predictor of cardiac prognosis in patients with chronic heart failure.

Authors:  Yoichiro Otaki; Hiroki Takahashi; Tetsu Watanabe; Shinpei Kadowaki; Taro Narumi; Yuki Honda; Hiromasa Hasegawa; Shintaro Honda; Akira Funayama; Satoshi Nishiyama; Takanori Arimoto; Tetsuro Shishido; Takehiko Miyashita; Takuya Miyamoto; Isao Kubota
Journal:  Clin Res Cardiol       Date:  2013-12-01       Impact factor: 5.460

9.  Estimating the probability of stroke in Korean hypertensive patients visiting tertiary hospitals using a risk profile from the Framingham study.

Authors:  Cheol Ung Choi; Chang Gyu Park
Journal:  BMC Neurol       Date:  2009-04-22       Impact factor: 2.474

10.  Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance.

Authors:  Stefan Buchner; Kurt Debl; Josef Haimerl; Behrus Djavidani; Florian Poschenrieder; Stefan Feuerbach; Guenter A J Riegger; Andreas Luchner
Journal:  J Cardiovasc Magn Reson       Date:  2009-06-01       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.